Abiopharma

FDA approve TRAZODONE HYDROCHLORIDE

FDA approve ALCOHOL

Plus Therapeutics Announces FDA Clearance of its Investigational New Drug Application using REYOBIQ™ for the Treatment of Childhood Brain Cancer

Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)

Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)

Jákvæð niðurstaða úr klínískri rannsókn fyrir fyrirhugaða hliðstæðu Alvotech við líftæknilyfið Xolair

Strengthening Preparedness against the Threat of Mosquito-Borne Diseases in the UK

Takeda Announces New Assignments of Directors

Indivior Notification

Last Day of Dealings on AIM

Takeda Announces the Publication of its Annual Report on Form 20-F for FY2024

Little Nightmares 3 Release Date Officially Set

Novartis announces expiration of Regulus Therapeutics tender offer

Addex Shareholders Approve All Resolutions at Annual General Meeting

Forte Biosciences Inc - Forte Biosciences Announces Pricing of $75 Million Public Offering